Rosatom’s Scientists Developed Prototypes of Irridum-192-based Micro Sources for Brachytherapy
Experts from Reactor Materials Institute (IRM), a company within Rosatom’s Scientific Division, have developed ionizing radiation sources based on iridium-192 for use in brachytherapy. The high-dose therapy using these sources is safe for patients and practitioners, while being effective in treating numerous malignant tumors, both intracavitary and interstitial. The uniqueness of Rosatom scientists’ solution is…